Projects per year
Personal profile
Research interests
My research is situated within the political sociology of medicine and pharmaceuticals. My main area of interest is the transparency of interactions between drug companies, patient organisations, and the health service. In addition, I examine social processes, especially lobbying, associated with the scientific assessment as well as pricing and reimbursement of medical technologies.
I draw on key traditions in political sociology, especially the work of Marx, Weber as well as C.W. Mills, Theda Skocpol, Stephen Lukes, and G. William Domhoff. I utilise multiple research methods ranging from ethnography and in-depth elite interviews to surveys, regression analysis, and social network analysis. I also have experience in using investigative methods, such as freedom of information requests. My research often results in creating large publicly available databases, some of which can be accessed through this website.
The initial focus of my work has been on Central-European countries such as Poland, Hungary, and Slovakia. More recently, I have been examining pharmaceutical policy in the UK, with a particular focus on England, as well as Nordic countries. Beyond Europe, I have a special interest in Japan and New Zealand.
I have published over 50 peer-reviewed papers in top-ranking journals including The British Medical Journal, Big Data and Society, Social Science and Medicine, Theory and Society and The British Journal of Sociology.
My research is frequently covered by the media, including The Sunday Times, The Independent, The Guardian, The Telegraph, The Daily Mail, and Sky News. Beyond the UK, it has featured, among others, in Le Monde, La Vanguardia, Le Soir, and Expressen.
My collaborative work with colleagues from Sweden and Japan has been supported by grants from international funders including the Swedish Research Council FORTE, Swedish Research Council VR, The Daiwa Anglo-Japanese Foundation and The Great Britain Sasakawa Foundation.
Research interests
- Conflicts of interest
- Lobbying
- Transparency
- Industry self-regulation
- Pharmaceuticals
- Drug pricing and reimbursement
- Health technology assessment
Recent and current research projects
Research affiliations
- Social Science Applied to Healthcase Improvement Research (SAPPHIRE) Group
- Department of Sociology, University of Cambridge
- Institute of Sociology, University of Warsaw
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Senior Lecturer, Department of Social & Policy Sciences
2020 → 2023
Lecturer, Department of Social & Policy Sciences
2015 → 2020
Prize Fellow, Department of Social & Policy Sciences
2013 → 2015
Research Associate, University of Leicester
2011 → 2013
Doctor of Philosophy, University of Cambridge
2007 → 2013
Master of Arts, University of Warsaw
2002 → 2007
Keywords
- HM Sociology
- Power
- Transparency
- Conflicts of interest
- Disclosure
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
ESRC IAA - Transparency impact
Ozieranski, P. (PI) & Rickard, E. (Researcher)
Economic and Social Research Council
1/02/25 → 31/08/25
Project: Research council
-
Sasakawa Foundation - Transparency in the UK and Japan
Ozieranski, P. (PI)
The Great Britain Sasakawa Foundation
15/08/23 → 14/08/25
Project: UK charity
-
Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations
Ozieranski, P. (PI)
1/01/21 → 31/12/24
Project: Other
-
The Future of Community Pharmacy in England: Policy, Stakeholder and Public Perspectives
Jones, M. (PI), Watson, M. (CoI) & Ozieranski, P. (PI)
23/01/17 → 23/01/20
Project: Research-related funding
-
What can be learnt from the new pharmaceutical industry payment disclosures?
Ozieranski, P. (PI)
1/01/17 → 31/03/21
Project: Other
-
Patterns of company misconduct, recidivism, and complaint resolution delays: A temporal analysis of UK pharmaceutical industry self-regulation within the European context
Mulinari, S., Pashley, D. & Ozieranski, P., 31 Jan 2025, In: Regulation and Governance. 19, 1, p. 200-217 18 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (SciVal) -
Pharmaceutical industry payments to healthcare professional organisations in the United Kingdom: a seven-year cross-sectional analysis of the Disclosure UK database from 2015 to 2021
Murayama, A., Fabbri, A., Scholfield, H. & Ozieranski, P., 31 Jan 2025, In: Journal of the Royal Society of Medicine (JRSM). 118, 1, p. 16-25 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (SciVal) -
Pharmaceutical Industry Payments to Patient Organizations in Poland: Analysis of the Patterns, Evolution, and Structure of Connections
Makowska, M., Mulinari, S. & Ozieranski, P., 30 Apr 2025, In: International Journal of Social Determinants of Health and Health Services. 55, 2, p. 199-212 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Self-regulation of UK's pharmaceutical industry
Ozieranski, P., Mulinari, S., Colombo, C. & Mintzes, B., 28 May 2025, In: BMJ (Clinical research ed.). 389, p. r1065 r1065.Research output: Contribution to journal › Editorial › peer-review
-
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation
Ozieranski, P., Rickard, E. & Mulinari, S., 7 Jan 2025, (E-pub ahead of print) In: BMJ Evidence-Based Medicine. 6 p., bmjebm-2024-113101.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Data set for "A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups"
Rickard, E. (Creator) & Ozieranski, P. (Creator), University of Bath, 28 May 2021
DOI: 10.15125/BATH-00943
Dataset
-
Dataset for "A patient-industry complex? Investigating the financial dependency of UK patient organisations on drug company funding"
Ozieranski, P. (Creator), Pitter, J. (Creator), Rickard, E. (Creator), Mulinari, S. (Creator) & Csanadi, M. (Creator), University of Bath, 7 Dec 2021
DOI: 10.15125/BATH-00904
Dataset
-
Underreporting of drug industry payments to patient organisations in the UK (2012-2016)
Ozieranski, P. (Creator), Csanadi, M. (Creator), Rickard, E. (Creator) & Mulinari, S. (Creator), University of Bath, 10 Jul 2020
DOI: 10.15125/BATH-00784
Dataset
-
Dataset for "Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis"
Rickard, E. (Creator) & Ozieranski, P. (Creator), University of Bath, 29 Mar 2023
DOI: 10.15125/BATH-01239
Dataset
-
Dataset for "The future of community pharmacy in England: policy, stakeholder and public perspectives"
Paloumpi, E. (Creator), Ozieranski, P. (Creator), Watson, M. (Creator) & Jones, M. (Creator), University of Bath, 18 Dec 2023
DOI: 10.15125/BATH-01317
Dataset
-
Media coverage of Parliamentary launch of "The future of community pharmacy in England: policy, stakeholder and public perspectives: a policy brief"
Jones, M. (Presenter), Paloumpi, E. (No value), Ozieranski, P. (No value) & Watson, M. (No value)
12 Jul 2023 → Aug 2023Activity: Media article or participation, blog › Media article or participation
-
A prescription for transparency: Reforming industry payments in UK healthcare
Ozieranski, P. (No value) & Rickard, E. (No value)
2025Activity: Media article or participation, blog › Blog
-
AUTH/3763/4/23 - Complainants v Novo Nordisk Allegation about transfers of value and activities
Ozieranski, P. (No value) & Mulinari, S. (No value)
2024Activity: Knowledge Exchange (Industry, Government, NGOs) › Giving evidence or preparing policy briefs
-
AUTH/3876/2/24 - Complainants v Novo Nordisk Allegations about disclosure of transfers of value
Rickard, E. (No value), Ozieranski, P. (No value) & Mulinari, S. (No value)
2025Activity: Knowledge Exchange (Industry, Government, NGOs) › Giving evidence or preparing policy briefs